|
Good morning. In today’s issue of Rheumatology Network, we highlight some key findings in rheumatology research we featured over the last several weeks. As always, we encourage your feedback: email the editor.
|
|
|
|
Early Diagnosis and Treatment of Lupus Essential in Racial/Ethnic Populations
|
A study published last month in Arthritis Care & Research shows that racial/ethnic minorities disproportionately have more severe cases of systemic lupus erythematosus (SLE). In this slideshow, we summarize the findings, but we'd like to know what you think. Email us your comments at areyes@mmhgroup.com.
|
|
Read more
|
|
|
|
ACR Updates Juvenile Arthritis Treatment Recommendations
|
The American College of Rheumatology and the Arthritis Foundation have updated the 2013 treatment guidelines for juvenile idiopathic arthritis (JIA), which includes juvenile non-systemic polyarthritis, sacroiliitis, and enthesitis. In this slideshow, we highlight the recommendations.
|
|
Read more
|
|
|
|
FDA Rheumatology Drug Approvals: Pediatric lupus, spondyloarthritis and more
|
From a new biosimilar to a first-ever approved drug to treat pediatric lupus patients, the Food & Drug Administration has approved several new medications in recent months. In this slideshow, we offer a brief overview of these new therapeutics.
|
|
Read more
|
|
|
|
Rheumatologist Physician Shortage by the Numbers
|
The rheumatology physician shortage is expected to decline through 2030, a report shows. Key recommendations have been made to close the gap in services.
|
|
Read more
|
